Cytodyn Inc (CYDY)

[fung_derf]

What is actually EXTREMELY interesting is this.....

In addition to the above statements, CytoDyn employed stock promotion firms that created
dozens of newsletters and internet postings to hype investment in CytoDyn and promote the use
of leronlimab as a COVID- 19 treatment, including firms named Emerging Growth, Proactive
Investors LLC, RedChip Companies, Inc., and the Wall Street Reporter.
For example. with respect to future leronlimab sales, on or about June 12, 2020, Emerging
Growth stated that CytoDyn. a company with no history of operational capacity, “expects to
produce 1.5 million vials of leronlimab in the next half of 2020 for 375,000 patients,” generating
“$2.5 billion in sales this year,” and “an estimated 6 million vials” for “$9.0 billion in revenue” in
2021 “if leronlimab receives regulatory approval.” The report concluded that “t’s astonishing
how undervalued this stock seems to be. . . . With close to $12 billion in revenues likely in the next
1 .5 years investors need to ask why the stock is trading at a 90% discount to just one times sales.
This is in pole position to be the first FDA approved drug to treat COVID-19.”

I recall someone had questioned the legitimacy of black ops....Almost verbatim

Black-Ops

06/11/20 10:34 PM

#84119 RE: Black-Ops #81567

A corrected Big Picture.

Just reviewed my earlier post. Note I was guessing 1 billion in revenue from Covid-19

Note that my Earnings guess per billion in revs is 1$ per share.

In todays conference call my numbers, the highest estimates on the street for Covid-19, now appear to be quite underestimated.

Nader P believes 2 1/2 billion from Covid-19 this year and 9 billion next year.

Think about that.

Under my EPS guess, earnings per share from Covid-19 will be 1$ per Billion in revenue, 9$ per share minus General and Administrative costs and all the costs of the numerous FDA Trials CYDY will engage.

Each trial may or might double Market cap again.

Others use the 10X Revenue valuation method. Lets use it as well.

2021 90 billion market cap based on 9 billion in revenue.

60 X current valuations which is close to 1 1/2 billion = 180$ per share.

If any readers recall my Big Picture posts, remember this post.

This could be the greatest victory I have witnessed. Never sell all your shares.

Meanwhile, even then there was this guy trying to warn people...

fung_derf

Member Level
Re: Zuess421 post# 83687

Wednesday, June 10, 2020 3:18:14 PM

Post#
83689
of 229365
Of course he CAN sell, but why would he?? This could be AAPL stock and I'd be concerned if Stevve Jobs was dumping a large portion right before his new iPhone was released.
You guys keep talking about any day now. Meanwhile, the volume is dropping off, the share price is trending down, and officers are selling stock.
I don't know how many indicators you all need?!